| Lawrence Jeffrey Rissman, MD | |
|
1212 Pleasant St Ste Ll3, Des Moines, IA 50309-1414 | |
| (515) 241-8861 | |
| (515) 241-8855 |
| Full Name | Lawrence Jeffrey Rissman |
|---|---|
| Gender | Male |
| Speciality | Pathology - Cytopathology |
| Location | 1212 Pleasant St Ste Ll3, Des Moines, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891780904 | NPI | - | NPPES |
| 6107151 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 21307 (Iowa) | Primary |
| Entity Name | Regional Laboratory Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891805958 PECOS PAC ID: 6901709062 Enrollment ID: O20040128000391 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce this risk, according to a new study from researchers in Spain.
A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 9 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce this risk, according to a new study from researchers in Spain.
A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence Jeffrey Rissman, MD 1212 Pleasant St Ste Ll3, Des Moines, IA 50309-1414 Ph: (515) 241-8861 | Lawrence Jeffrey Rissman, MD 1212 Pleasant St Ste Ll3, Des Moines, IA 50309-1414 Ph: (515) 241-8861 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce this risk, according to a new study from researchers in Spain.
A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health.
› Verified 9 days ago
Ramona Ann Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8638 | |
Dr. Carolyn Su-ying Pease, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Avenue, Mercy Medical Center, Des Moines, IA 50314 Phone: 515-643-8533 Fax: 515-643-8911 | |
Dr. Lorie A. Montag, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant, Suite #ll3, Des Moines, IA 50309 Phone: 515-241-8861 Fax: 515-241-8855 | |
Timothy Floyd Drevyanko, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Jacob Edward Sramek, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite Ll3, Des Moines, IA 50309 Phone: 515-241-8866 | |
Edward Fredric Loeb, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Richard Kent Scupham, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 |